• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻症 COVID-19 肺炎急性期持续时间的早期预测指标。

Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.

机构信息

Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, UK.

Department of Clinical and Experimental Medicine, Metabolic Diseases Unit, Magna Graecia University, Catanzaro, Italy.

出版信息

J Med Virol. 2021 Jan;93(1):513-517. doi: 10.1002/jmv.26281. Epub 2020 Jul 21.

DOI:10.1002/jmv.26281
PMID:32644215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361230/
Abstract

OBJECTIVE

In this study, we aimed to highlight the common early-stage clinical and laboratory variables independently related to the acute phase duration in patients with uncomplicated coronavirus disease (COVID-19) pneumonia.

METHODS

In hospitalized patients, the acute phase disease duration was followed using the Brescia-COVID respiratory severity scale. Noninvasive ventilation was administered based on clinical judgment. Patients requiring oropharyngeal intubation were excluded from the study. For parameters to be measured at the hospital entrance, age, clinical history, National Early Warning Score 2 (a multiparametric score system), partial pressure of oxygen in arterial blood/fraction of inspired oxygen (P/F ratio), C-reactive protein, and blood cell count were selected.

RESULTS

In 64 patients, age (direct relationship), P/F, and platelet number (inverse relationship) independently accounted for 43% of the acute phase duration of the disease (P < .001).

CONCLUSIONS

For the first time, the present results revealed that the acute phase duration of noncomplicated pneumonia, resulting from severe acute respiratory syndrome coronavirus 2, is independently predicted from a patient's age, as well as based on the hospital entrance values of P/F ratio and peripheral blood platelet count.

摘要

目的

本研究旨在强调与单纯性 COVID-19 肺炎患者急性期持续时间相关的常见早期临床和实验室变量。

方法

在住院患者中,使用布雷西亚-COVID 呼吸严重程度量表来监测急性期疾病持续时间。根据临床判断给予无创通气。排除需要经口气管插管的患者。对于入院时需要测量的参数,选择年龄、临床病史、国家早期预警评分 2(多参数评分系统)、动脉血氧分压/吸入氧分数(P/F 比值)、C 反应蛋白和血细胞计数。

结果

在 64 例患者中,年龄(直接关系)、P/F 和血小板计数(反比关系)独立解释了疾病急性期持续时间的 43%(P<0.001)。

结论

本研究首次揭示,年龄以及入院时的 P/F 比值和外周血血小板计数可以独立预测由严重急性呼吸综合征冠状病毒 2 引起的非复杂性肺炎的急性期持续时间。

相似文献

1
Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.轻症 COVID-19 肺炎急性期持续时间的早期预测指标。
J Med Virol. 2021 Jan;93(1):513-517. doi: 10.1002/jmv.26281. Epub 2020 Jul 21.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.双盲、随机、对照临床试验评估同种异体间充质基质细胞治疗 COVID-19 所致急性呼吸窘迫综合征患者的疗效(COVID-AT):一项随机对照试验的研究方案的结构总结。
Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.
4
Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.COVID-19 患者严重急性呼吸综合征冠状病毒 2 病毒阳性持续时间的早期危险因素。
Clin Infect Dis. 2020 Nov 19;71(16):2061-2065. doi: 10.1093/cid/ciaa490.
5
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019.分析拭子中可检测到的 SARS-COV-2 RNA 与 2019 年冠状病毒病患者疾病严重程度的关系。
J Med Virol. 2021 Feb;93(2):794-802. doi: 10.1002/jmv.26307. Epub 2020 Jul 27.
6
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.沙利鲁单抗对比标准治疗用于住院 COVID-19 肺炎患者的早期治疗:SARTRE:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 16;21(1):794. doi: 10.1186/s13063-020-04633-3.
7
Covid-19 severe hypoxemic pneumonia: A clinical experience using high-flow nasal oxygen therapy as first-line management.Covid-19 严重低氧性肺炎:使用高流量鼻氧疗作为一线治疗的临床经验。
Respir Med Res. 2021 Nov;80:100834. doi: 10.1016/j.resmer.2021.100834. Epub 2021 Jun 4.
8
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.儿童 COVID-19 患者不同严重程度和过敏状态的 182 例临床特征。
Allergy. 2021 Feb;76(2):510-532. doi: 10.1111/all.14452. Epub 2020 Sep 3.
9
[Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome].无创正压通气和高流量鼻导管氧疗对2019冠状病毒病急性呼吸窘迫综合征患者临床疗效的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):708-713. doi: 10.3760/cma.j.cn121430-20210104-00002.
10
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle.低睾酮预示着 COVID-19 患者发生低氧性呼吸功能不全和死亡:COVID 谜题的又一块拼板。
J Endocrinol Invest. 2022 Apr;45(4):753-762. doi: 10.1007/s40618-021-01700-7. Epub 2021 Nov 18.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Machine learning-based CT radiomics method for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study.基于机器学习的CT影像组学方法预测新型冠状病毒肺炎患者住院时间:一项多中心研究
Ann Transl Med. 2020 Jul;8(14):859. doi: 10.21037/atm-20-3026.
3
Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding.肥胖症会延长 COVID-19 患者的住院时间,并可能影响 SARS-CoV-2 的脱落。
Obes Res Clin Pract. 2020 May-Jun;14(3):205-209. doi: 10.1016/j.orcp.2020.05.009. Epub 2020 Jun 4.
4
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.1420 例轻症至中症 2019 年冠状病毒病欧洲患者的临床和流行病学特征。
J Intern Med. 2020 Sep;288(3):335-344. doi: 10.1111/joim.13089. Epub 2020 Jun 17.
5
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.2020 年 1 月至 3 月在中国浙江省感染 SARS-CoV-2 的患者的病毒载量动态和疾病严重程度:回顾性队列研究。
BMJ. 2020 Apr 21;369:m1443. doi: 10.1136/bmj.m1443.
6
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients.与新冠病毒肺炎患者疾病严重程度及住院时间相关的危险因素。
J Infect. 2020 Jul;81(1):e95-e97. doi: 10.1016/j.jinf.2020.04.008. Epub 2020 Apr 17.
7
Thrombocytopenia and its association with mortality in patients with COVID-19.血小板减少症及其与 COVID-19 患者死亡率的关系。
J Thromb Haemost. 2020 Jun;18(6):1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4.
8
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日,14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
9
A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.一种用于早期预测严重 2019 冠状病毒病(COVID-19)的工具:来自中国武汉和广东的多中心研究使用风险列线图。
Clin Infect Dis. 2020 Jul 28;71(15):833-840. doi: 10.1093/cid/ciaa443.
10
Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.《2019冠状病毒病患者治疗手册》。第2.0版,2020年3月13日。
Infez Med. 2020;28(2):143-152.